By Nascent Biotech Posted November 9, 2019 In Hugwil&Glassy Cancer 66 (003)2019-11-092019-11-09http://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.pngNascent Biotechhttp://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.png200px200px 0 Hugwil&Glassy Cancer 66 (003) Recent PostsLetter to Shareholders from Sean CarrickMessage From Senior ManagementVIDEO: Nascent Biotech CEO Sean Carrick at the Emerging Grown ConferenceNascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run
